AtlasXomics
PrivateLast Round
Grant
Apr 8, 2025
Total Funding Raised
$15.68M
Company Overview
AtlasXomics is a biotechnology company that develops a spatial epigenome technology platform designed to provide multi-omics tissue atlases for researchers and clinicians.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtlasXomics Comparables
Compare AtlasXomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vizgen | 77% | |
| OmicInsight Corporation | 74% | |
| Takara Bio Inc. | 74% |
AtlasXomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 8, 2025 | ||||
| Grant | Sep 19, 2023 | ||||
| Grant | Sep 16, 2022 | ||||
| Grant | May 1, 2022 | ||||
| Series A | Feb 8, 2022 | ||||
Seed | Mar 30, 2021 |
AtlasXomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Connecticut Innovations | Seed, Series A |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Elm Street Ventures | Seed |
| FORGE | Grant |
| Broadfield Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2025
$70K grant received from FORGE.
- Sep 19, 2023
$1.8M grant from the National Cancer Institute
AtlasXomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AtlasXomics's valuation, stock price, and market status.
Is AtlasXomics a public or private company?
AtlasXomics is a private company.
What is the current stock price of AtlasXomics?
AtlasXomics is a private company with no public stock price. No recent secondary market data is available.
How much is AtlasXomics worth (valuation)?
Valuation information for AtlasXomics is not publicly available.
Can I buy AtlasXomics stock?
AtlasXomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AtlasXomics's last funding round?
AtlasXomics's most recent funding round was Grant on September 19, 2023.
Who are the main investors in AtlasXomics?
Key investors in AtlasXomics include National Cancer Institute.
Will AtlasXomics IPO soon?
No public IPO plans have been announced for AtlasXomics.
How can I track AtlasXomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AtlasXomics's secondary market activity and sign up for updates.